LMGAM
REGN icon

Liberty Mutual Group Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Liberty Mutual Group Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,092
Closed -$1.25M – 615
2018
Q3 		$1.25M Hold
3,092
– – 0.03% 282
2018
Q2 		$1.07M Buy
3,092
+30
+1% +$9.38K 0.03% 346
2018
Q1 		$1.05M Hold
3,062
– – 0.03% 355
2017
Q4 		$1.15M Sell
3,062
-24
-0.8% -$9.72K 0.03% 383
2017
Q3 		$1.38M Sell
3,086
-1,690
-35% -$804K 0.08% 305
2017
Q2 		$2.35M Buy
4,776
+721
+18% +$316K 0.1% 236
2017
Q1 		$1.57M Sell
4,055
-1,540
-28% -$571K 0.06% 445
2016
Q4 		$2.05M Buy
5,595
+314
+6% +$119K 0.07% 347
2016
Q3 		$2.12M Sell
5,281
-337
-6% -$135K 0.08% 304
2016
Q2 		$1.96M Buy
5,618
+476
+9% +$183K 0.07% 313
2016
Q1 		$1.85M Buy
5,142
+519
+11% +$214K 0.08% 304
2015
Q4 		$2.51M Buy
4,623
+279
+6% +$151K 0.1% 270
2015
Q3 		$2.02M Sell
4,344
-635
-13% -$341K 0.08% 325
2015
Q2 		$2.54M Sell
4,979
-1,763
-26% -$860K 0.09% 268
2015
Q1 		$3.04M Buy
6,742
+47
+0.7% +$19.9K 0.09% 235
2014
Q4 		$2.75M Sell
6,695
-618
-8% -$243K 0.09% 272
2014
Q3 		$2.64M Sell
7,313
-418
-5% -$140K 0.09% 278
2014
Q2 		$2.18M Sell
7,731
-110
-1% -$32.6K 0.07% 390
2014
Q1 		$2.35M Buy
7,841
+1,016
+15% +$313K 0.08% 314
2013
Q4 		$1.88M Buy
6,825
+2,114
+45% +$608K 0.07% 368
2013
Q3 		$1.48M Buy
4,711
+1,070
+29% +$281K 0.06% 407
2013
Q2 		$819K Buy
+3,641
New +$848K 0.03% 649

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Liberty Mutual Group Asset Management's REGN Position: Q4 2018 in Review

Liberty Mutual Group Asset Management sold out of Regeneron Pharmaceuticals (REGN) in Q4 2018, closing a stake of 3,092 shares — an estimated $1.25M sold.

Liberty Mutual Group Asset Management first reported a position in REGN in Q2 2013 and held it in 22 quarters. The position peaked at $3.04M in Q1 2015. 671 funds tracked by Wall St. Rank hold REGN as of Q4 2018.

  • Liberty Mutual Group Asset Management reported no remaining Regeneron Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Liberty Mutual Group Asset Management sold 3,092 Regeneron Pharmaceuticals shares in Q4 2018, an estimated $1.25M.
  • Liberty Mutual Group Asset Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 22 quarters.
  • Liberty Mutual Group Asset Management's Regeneron Pharmaceuticals position peaked at $3.04M in Q1 2015.
  • 671 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2018.

Based on Liberty Mutual Group Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.